Relmada’s depression drug fails to meet late-stage study goal
Relmada will continue to study REL-1017, its lead treatment, as an adjuntive or in combination with other depression drugs
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Major Depressive Disorder treatment
Sun Pharma to introduce its version of Vortioxetine in India
Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in…